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In recent years, significant progress has been achieved in the computational design of 
functional artificial enzymes. When combined with directed evolution protocols, their 
efficiencies are comparable to those obtained with catalytic antibodies.[1]  
In comparison, the in silico creation of artificial metalloenzymes remains challenging. This 
may be due to the difficulty in computing both the transition states for metal-catalyzed 
reactions and the corresponding entatic state for  a metalloenzyme.[2] 
To circumvent these challenges, two complementary approaches have been successfully 
pursued: 
i) Small molecule “enzyme models” can be designed to mimick the active site of a 
metalloenzyme of interest. Although these rarely rival natural enzymes in terms of catalytic 
efficiency, they often yield precious structural and mechanistic information.[3] 
ii) Catalytically competent moieties can be introduced in a protein scaffold to yield artificial 
metalloenzymes. In this context, sperm whale myoglobin – a globular protein consisting of 
eight alpha helices and a heme prostetic group surrounded by a hydrophobic pocket, Figure 1a 
– has been exploited as a stable scaffold for the creation of artificial metalloenzymes.[4]  
In a recent study, Yi Lu and coworkers have rationally designed and structurally characterized 
a functional bacterial nitric oxide reductase (NOR) within a myoglobin scaffold.[4b] This 
achievement is particularly noteworthy as neither the X-ray structure nor an unambiguous 
reaction mechanism of NOR have been elucidated.[5] 
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Nitric oxide reductase (NOR) is a key enzyme in the nitrogen cycle and thus is critical to all 
life forms on Earth. It catalyzes the two electron reduction of NO to N2O according to 
Equation 1. 
Sequence alignment and structural threading suggested that NORs are structurally 
homologous to subunit I of heme copper oxidases (HCO, Figure 1c).[5a] Most interestingly, 
some heme copper oxidases (HCOs) and NORs show reciprocal promiscuity towards their 
substrates albeit with significantly reduced efficiencies: NOR from Paracoccus denitrificans 
reduces dioxygen to water (according to Equation 2) and cytochrome cbb3 from Pseudomonas 
stutzeri catalyzes the reduction of NO to N2O.
[6] 
Major structural differences between both enzymes include:  
i) the substitution of CuB in HCO by FeB in NOR 
ii) the presence of conserved glutamate(s) near the catalytic site in NOR 
2NO + 2H+ + 2e  → N2O + H2O  (Eq. 1) 
O2 + 4H
+ + 4e  → 2 H2O  (Eq.2) 
      
Figure 1: A) Cartoon representation of wildtype holo-myoglobin with histidines H64 (FeB), H93 (heme) involved 
in metal complexation in NOR-model FeBMb. Side chains of residues (L29, F43, V68) targeted for mutagenesis 
are highlighted in magenta (pdb code 1JP6). B) Active site of NOR-model FeBMb with mutations L29H, F43H, 
V68E (pdb code 3K9Z); the water molecule coordinated to FeB is depicted as a red sphere. C) Active site of 
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cytochrome c oxidase from bovine heart (pdb code 2OCC); copper is depicted as a green sphere; the peroxo-
bridge between iron and copper has been omitted. Pictures from pdb files have been generated with Pymol from 
DeLano Scientific Inc.  
 
In 2000 Yi Lu and coworkers engineered an HCO-model within myoglobin (termed CuBMb). 
For this purpose, they created a metal binding site by introducing two histidine residues 
which, combined with the distal His64, provide a tetrahedral coordination environment for 
copper similar to cytochrome c oxidase from bovine heart (Figure 1c).[4f] As reported for 
natural HCOs, this artificial metalloenzyme CuBMb was later shown to catalyze the reduction 
of NO to N2O.
[4g] 
Building upon this and relying on force field modelling, the copper binding site was modified 
to accommodate an iron ion by introduction of an additional critical glutamate residue, thus 
providing a (His)3Glu binding site for the non-heme FeB (Figure 1b). 
The resulting artificial FeBMb NOR was characterized by X-ray crystallography, confirming 
the predictive power of the semi-quantitative computational design (ie. Zn parameters were 
used to model the FeB site). Additional striking features of the FeBMb are: 
i) In addition to the (His)3Glu coordination,  a water molecule is bound to FeB thereby 
expanding the coordination sphere to 5+1 (with a weak contact with the second oxygen of 
glutamate).[5,7] 
ii) The Fe-centers (heme-Fe and FeB) seem to be spin coupled in analogy to NOR as 
demonstrated by EPR-spectroscopy and redox potential determination.   
Next, the behaviour of the fully reduced artificial NOR FeBMb was studied under single 
turnover conditions. Subsequently a second turnover was approximated by re-reduction of the 
artificial NOR by addition of dithionite. A control experiment with wildtype Mb in the 
presence of  added Fe(II) did not lead to the production of N2O even after the addition of 
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dithionite. This is surprising as Fe(II) combined with dithionite in the absence of protein led 
to N2O formation: approximately half of what was produced in the presence of NOR FeBMb.  
The mode of action of NOR remains a matter of debate while different mechanisms have been 
presented in the literature.[5] A critical issue in this context is the role of both metals in the 
binding and activation of the substrates, (Figure 2a): 
i) Do both NO-molecules bind to FeB (the cis:FeB-mechanism)?
[8]
ii) Does one NO bind to the heme b3 center and one to FeB (the trans-mechanism)?
[9]
iii) A third, intermolecular mechanism (the cis:b3-mechanism) has been suggested for NO
reduction in cytochrome cbb3 oxidase from Pseudomonas stutzeri: a free NO attacks a heme-
bound nitrosyl.[10]  
Recently, Collman, Solomon and coworkers presented the first functional small molecule 
model for the active site of NOR (Figure 2 b).[11] Spectroscopic characterisation of the NO 
complexes in different oxidation states point towards a trans-mechanism.  
Figure 2: A: Proposed intermediates in the formation of N2O from NO by NOR; B: functional small molecule 
model reported by Collman, Solomon and coworkers.[11]   
Overall, the groundbreaking study by Lu and coworkers has opened the way towards the 
rational design of artificial metalloenzymes for more challenging reactions. For the artificial 
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NOR, several issues deserve further scrutiny: catalytic efficiency (kcat, KM and total turnover 
number) as well as detailed reaction mechanism (mode of NO binding, proton shuttling, 
product release etc.). 
In a broader perspective, the use of more elaborate computational algorithms, combined with 
efficient directed evolution protocols should enable the creation and optimization of highly 
versatile artificial metalloenzymes in a variety of protein folds.[12] 
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One Site Fits All! Yi Lu and coworkers have reported the conversion of sperm-whale 
Myoglobin into a functional nitric oxide reductase. For this purpose, they designed a second 
metal binding site into the wildtype holo-protein and demonstrated NO reduction with the 
structurally characterized model, making thereby a significant contribution to the rapidly 
developing field of artificial metalloenzymes.   
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